Boehringer Ingelheim Korea
- Address: 16F, Yonsei Severance Bldg., 10, Tongil-ro, Jung-gu, Seoul, Korea
- Website: www.boehringer-ingelheim.com/kr
Boehringer Ingelheim Korea, a subsidiary of the research driven pharmaceutical leader Boehringer Ingelheim, was established in 1976.
With over 250 employees, the company is dedicated to improving the lives of current and future generations through the supply of innovative pharmaceuticals in both the human and animal health sectors. Boehringer Ingelheim Korea continuously strives to create value through innovation in areas with high unmet medical needs.
In human pharmaceuticals, the company has built a portfolio in cardiovascular and metabolic diseases, oncology, respiratory diseases, immunology and central nervous system disorders, focusing on the development of related therapies.
As a responsible corporate citizen, Boehringer Ingelheim Korea has supported the Wunsch Medical Award for the advancement of medical science in Korea for the past 30+ years.
The company also contributes to the local community through charitable donations and volunteer activities.
With over 250 employees, the company is dedicated to improving the lives of current and future generations through the supply of innovative pharmaceuticals in both the human and animal health sectors. Boehringer Ingelheim Korea continuously strives to create value through innovation in areas with high unmet medical needs.
In human pharmaceuticals, the company has built a portfolio in cardiovascular and metabolic diseases, oncology, respiratory diseases, immunology and central nervous system disorders, focusing on the development of related therapies.
As a responsible corporate citizen, Boehringer Ingelheim Korea has supported the Wunsch Medical Award for the advancement of medical science in Korea for the past 30+ years.
The company also contributes to the local community through charitable donations and volunteer activities.